Prevention and Rehabilitation After Heart Transplantation: A Clinical Consensus Statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a Section of ESOT.

Autor: Simonenko M; Cardiopulmonary Exercise Test Research Department, Heart Transplantation Outpatient Department, V. A. Almazov National Medical Research Centre, St. Petersburg, Russia., Hansen D; REVAL and BIOMED Rehabilitation Research Center, Hasselt University, Hasselt, Belgium.; Heart Centre Hasselt, Jessa Hospital, Hasselt, Belgium., Niebauer J; University Institute of Sports Medicine, Prevention and Rehabilitation, Paracelsus Medical University, Salzburg, Austria., Volterrani M; Cardio-Pulmonary Department, IRCCS San Raffaele Roma, Rome, Italy., Adamopoulos S; Heart Failure and Heart Transplantation Unit, Onassis Cardiac Surgery Center, Athens, Greece., Amarelli C; Department of Cardiac Surgery and Transplants, Monaldi Hospital, Azienda dei Colli, Naples, Italy., Ambrosetti M; Cardiovascular Rehabilitation Unit, ASST Crema, Santa Marta Hospital, Rivolta D'Adda, Italy., Anker SD; Department of Cardiology (CVK), Berlin Institute of Health Center for Regenerative Therapies (BCRT), German Centre for Cardiovascular Research (DZHK) Partner Site Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany., Bayes-Genis A; University Hospital Germans Trias and Pujol de Badalona, Badalona, Spain., Ben Gal T; Heart Failure Unit, Cardiology Department, Rabin Medical Center, Petah Tikva and Sackler, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Bowen TS; School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom., Cacciatore F; Department of Translational Medicine, University of Naples 'Federico II', Naples, Italy., Caminiti G; Cardio-Pulmonary Department, IRCCS San Raffaele Roma, Rome, Italy., Cavarretta E; Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome, Italy.; Mediterranea Cardiocentro, Naples, Italy., Chioncel O; Emergency Institute for Cardiovascular Diseases 'Prof. C. C. Iliescu', Bucharest, Romania.; University of Medicine Carol Davila, Bucharest, Romania., Coats AJS; Heart Research Institute, Sydney, NSW, Australia., Cohen-Solal A; Cardiology Department, University of Paris, INSERM UMRS-942, Hopital Lariboisiere, AP-HP, Paris, France., D'Ascenzi F; Division of Cardiology, Department of Medical Biotechnologies, University of Siena, Siena, Italy., de Pablo Zarzosa C; Department of Cardiology, Ramón y Cajal University Hospital, Madrid, Spain., Gevaert AB; Research Group Cardiovascular Diseases, Genetics, Pharmacology and Physiopathology of Heart, Blood Vessels and Skeleton (GENCOR) Department, University of Antwerp, Antwerp, Belgium.; Department of Cardiology, Antwerp University Hospital, Edegem, Belgium., Gustafsson F; Department of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Kemps H; Department of Cardiology, Maxima Medical Centre, Eindhoven, Netherlands.; Department of Industrial Design, Eindhoven University of Technology, Eindhoven, Netherlands., Hill L; School of Nursing and Midwifery, Queen's University Belfast, Belfast, United Kingdom., Jaarsma T; Department of Health, Medicine and Caring Science, Linköping University, Linköping, Sweden.; Julius Center, University Medical Center Utrecht, Utrecht, Netherlands., Jankowska E; Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland., Joyce E; Department of Cardiology, Mater University Hospital, Dublin, Ireland.; School of Medicine, University College Dublin, Dublin, Ireland., Krankel N; Universitätsmedizin Berlin Campus Benjamin Franklin Klinik für Kardiologie Charite, Berlin, Germany., Lainscak M; General Hospital Murska Sobota, Murska Sobota, Slovenia., Lund LH; Department of Medicine, Karolinska Institutet and Heart and Vascular Theme, Karolinska University Hospital, Stockholm, Sweden., Moura B; Armed Forces Hospital, Porto, Portugal.; Centre for Health Technologies and Services Research, Faculty of Medicine of University of Porto, Porto, Portugal., Nytrøen K; Department of Cardiology, Oslo University Hospital Rikshospitalet, Oslo, Norway., Osto E; Division of Physiology and Pathophysiology, Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Medical University of Graz, Graz, Austria.; Vetsuisse Faculty, University of Zurich, Zurich, Switzerland., Piepoli M; Dipartimento Scienze Biomediche per la Salute, Universita' Degli Studi di Milan, Milan, Italy.; Cardiologia Universitaria, IRCCS Policlinico San Donato, Milan, Italy., Potena L; University Hospital of Bologna, Bologna, Italy., Rakisheva A; Department of Cardiology, Scientific Institution of Cardiology and Internal Diseases, Almaty, Kazakhstan.; Department of Cardiology, Kapshagai City Hospital, Almaty, Kazakhstan., Rosano G; St. George's Hospital NHS Trust University of London, London, United Kingdom., Savarese G; Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden., Seferovic PM; Faculty of Medicine and Heart Failure Center, University of Belgrade, Belgrade University Medical Center, Belgrade, Serbia., Thompson DR; School of Nursing and Midwifery, Queen's University Belfast, Belfast, United Kingdom., Thum T; Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School and Fraunhofer Institute for Toxicology and Experimental Research, Hannover, Germany., Van Craenenbroeck EM; Research Group Cardiovascular Diseases, Genetics, Pharmacology and Physiopathology of Heart, Blood Vessels and Skeleton (GENCOR) Department, University of Antwerp, Antwerp, Belgium.; Department of Cardiology, Antwerp University Hospital, Edegem, Belgium.
Jazyk: angličtina
Zdroj: Transplant international : official journal of the European Society for Organ Transplantation [Transpl Int] 2024 Jun 19; Vol. 37, pp. 13191. Date of Electronic Publication: 2024 Jun 19 (Print Publication: 2024).
DOI: 10.3389/ti.2024.13191
Abstrakt: Little is known either about either physical activity patterns, or other lifestyle-related prevention measures in heart transplantation (HTx) recipients. The history of HTx started more than 50 years ago but there are still no guidelines or position papers highlighting the features of prevention and rehabilitation after HTx. The aims of this scientific statement are (i) to explain the importance of prevention and rehabilitation after HTx, and (ii) to promote the factors (modifiable/non-modifiable) that should be addressed after HTx to improve patients' physical capacity, quality of life and survival. All HTx team members have their role to play in the care of these patients and multidisciplinary prevention and rehabilitation programmes designed for transplant recipients. HTx recipients are clearly not healthy disease-free subjects yet they also significantly differ from heart failure patients or those who are supported with mechanical circulatory support. Therefore, prevention and rehabilitation after HTx both need to be specifically tailored to this patient population and be multidisciplinary in nature. Prevention and rehabilitation programmes should be initiated early after HTx and continued during the entire post-transplant journey. This clinical consensus statement focuses on the importance and the characteristics of prevention and rehabilitation designed for HTx recipients.
Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
(Copyright © 2024 Simonenko, Hansen, Niebauer, Volterrani, Adamopoulos, Amarelli, Ambrosetti, Anker, Bayes-Genis, Ben Gal, Bowen, Cacciatore, Caminiti, Cavarretta, Chioncel, Coats, Cohen-Solal, D’Ascenzi, de Pablo Zarzosa, Gevaert, Gustafsson, Kemps, Hill, Jaarsma, Jankowska, Joyce, Krankel, Lainscak, Lund, Moura, Nytrøen, Osto, Piepoli, Potena, Rakisheva, Rosano, Savarese, Seferovic, Thompson, Thum and Van Craenenbroeck.)
Databáze: MEDLINE